Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.68 |
| ▸ | HPGD | P15428 | 6/20 | 0.68 |
| ▸ | MAPT | P10636 | 5/20 | 0.68 |
| ▸ | MEN1 | O00255 | 5/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | HTT | P42858 | 3/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | HTR6 | P50406 | 2/20 | 0.50 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.48 |
| ▸ | EDNRA | P25101 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19368319 | 0.95 | KDM4E (0.64) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL28988538 | 0.93 | MAPT (0.68) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL30352484 | 0.93 | MAPT (0.68) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL16171589 | 0.93 | KDM4E (0.59) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL14407598 | 0.92 | MAPT (0.70) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL17694120 | 0.91 | KDM4E (0.60) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL17694116 | 0.90 | KDM4E (0.56) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL16171612 | 0.90 | KDM4E (0.56) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL16171498 | 0.90 | KDM4E (0.56) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL25613235 | 0.90 | KDM4E (0.60) | KDM4EALDH1A1HPGDMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023098740-A1 | ORGANIC ROOM-TEMPERATURE ELECTROPHOSPHORESCENT MATERIAL, AND PREPARATION METHOD THEREFOR AND ORGANIC ELECTROLUMINESCENT DIODE THEREOF | 云南大学 | 2023-06-08 | — | — | WO | disclosed |
| EP-2772483-B1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | TOSOH CORP (JP) | 2017-03-29 | — | — | EP | disclosed |
| EP-2416392-B1 | Light emitting device and display unit | RICOH CO LTD (JP) | 2016-05-25 | — | — | EP | disclosed |
| US-9263682-B2 | Light emitting device and display unit | RICOH COMPANY, LTD. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-9206202-B2 | Carbazole derivative and semiconductor nanocrystal | RICOH COMPANY, LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| EP-2772483-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | Tosoh Corporation (JP) | 2014-09-03 | — | — | EP | disclosed |
| US-20130026426-A1 | CARBAZOLE DERIVATIVE AND SEMICONDUCTOR NANOCRYSTAL | RICOH COMPANY, LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20120032115-A1 | LIGHT EMITTING DEVICE AND DISPLAY UNIT | RICOH COMPANY, LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2416392-A2 | Light emitting device and display unit | Ricoh Company, Ltd. (JP) | 2012-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130026426-A1 | CARBAZOLE DERIVATIVE AND SEMICONDUCTOR NANOCRYSTAL | NAT1, AHR, ARSA | KDM4E 3482/4885ALDH1A1 1072/4885HPGD 3275/4885 |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | KDM4E 3740/4885ALDH1A1 2839/4885HPGD 1924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.